Brain iron redistribution in mesial temporal lobe epilepsy: a susceptibility-weighted magnetic resonance imaging

Zhiqiang Zhang1, Wei Liao2,3, Boris Bernhardt4

  • 1Department of Medical Imaging, Jinling Hospital, Nanjing University School of Medicine, 305# Eastern Zhongshan Rd, Nanjing, 210002, China. zhangzq2001@126.com.

BMC Neuroscience
|November 22, 2014
PubMed
Abstract

Insights

Iron levels are redistributed between brain structures in mesial temporal lobe epilepsy (mTLE). This iron redistribution correlates with epilepsy progression and clinical factors, offering new insights into mTLE pathogenesis.

Area of Science:

  • Neuroimaging
  • Neurology
  • Medical Physics

Background:

  • The role of iron in epilepsy pathophysiology remains unclear, particularly in subcortical brain regions.
  • Investigating iron distribution in mesial temporal lobe epilepsy (mTLE) is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To demonstrate whole-brain iron alterations in mTLE patients using in vivo susceptibility-weighted imaging (SWI).
  • To explore the clinical relevance of these iron changes in mTLE.

Main Methods:

  • Compared brain iron concentration using SWI phase values in 62 mTLE patients and 62 healthy controls.
  • Utilized voxel-wise analysis to identify differences in iron levels and their correlation with clinical parameters.

Main Results:

  • Decreased iron levels were observed in subcortical structures (substantia nigra, red nucleus, basal ganglia) and the cortex in mTLE patients.
  • Subcortical iron levels showed a negative correlation with cortical iron levels.
  • Cortical and basal ganglia iron concentrations correlated with epilepsy duration, age at seizure onset, and precipitating factors.

Conclusions:

  • SWI reveals a significant redistribution of iron between subcortical and cortical areas in mTLE.
  • The extent of iron redistribution is influenced by epilepsy progression and precipitating factors.
  • Brain iron redistribution may serve as a potential biomarker for monitoring mTLE clinical progression.

Related Concept Videos